Literature DB >> 12725761

Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis.

Maria A Rocca1, Domenico M Mezzapesa, Andrea Falini, Angelo Ghezzi, Vittorio Martinelli, Giuseppe Scotti, Giancarlo Comi, Massimo Filippi.   

Abstract

Previous work has suggested that functional reorganization of cortical areas might have a role in limiting the clinical impact of axonal pathology in patients with established multiple sclerosis (MS). Since there is evidence for irreversible tissue damage even in patients with early MS, we assessed, using functional MRI (fMRI) and a general search method, the brain pattern of movement-associated cortical activations in patients at presentation with clinically isolated syndromes (CIS) suggestive of MS. To elucidate the role of cortical reorganization in these patients, we also investigated the extent to which the fMRI changes correlated with the extent of overall axonal injury of the brain. From 16 right-handed patients at presentation with CIS and 15 right-handed, age- and sex-matched healthy volunteers, we obtained: (1). fMRI (repetitive flexion-extension of the last four fingers of the right hand), (2). conventional MRI scans, and (3). a new, unlocalized proton MR spectroscopy ((1)HMRS) sequence to measure the concentration of N-acetylaspartate of the whole brain (WBNAA). Compared to controls, patients with CIS had more significant activations of the contralateral primary somatomotor cortex (SMC), secondary somatosensory cortex, and inferior frontal gyrus. They also had significant decreased WBNAA concentration. Relative activation of the contralateral primary SMC was strongly correlated with WBNAA levels (r = -0.78, P < 0.001). This study shows that axonal pathology and functional cortical changes over a rather distributed sensorimotor network occur in patients at presentation with CIS suggestive of MS and that these two aspects of the disease are strictly correlated. This suggests that the increased functional recruitment of the cortex in these patients might have an adaptive role in limiting the clinical impact of irreversible tissue damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725761     DOI: 10.1016/s1053-8119(03)00043-0

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  23 in total

1.  Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis.

Authors:  Bertrand Audoin; My Van Au Duong; Jean-Philippe Ranjeva; Danielle Ibarrola; Irina Malikova; Sylviane Confort-Gouny; Elisabeth Soulier; Patrick Viout; André Ali-Chérif; Jean Pelletier; Patrick J Cozzone
Journal:  Hum Brain Mapp       Date:  2005-03       Impact factor: 5.038

Review 2.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

3.  Activation volume vs BOLD signal change as measures of fMRI activation - Its impact on GABA - fMRI activation correlation.

Authors:  Pallab K Bhattacharyya; Micheal D Phillips; Lael A Stone; Mark J Lowe
Journal:  Magn Reson Imaging       Date:  2017-06-17       Impact factor: 2.546

4.  A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis.

Authors:  Maria A Rocca; Domenico M Mezzapesa; Angelo Ghezzi; Andrea Falini; Vittorio Martinelli; Giuseppe Scotti; Giancarlo Comi; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

5.  Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients?

Authors:  Maria A Rocca; Martina Absinta; Angelo Ghezzi; Lucia Moiola; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 6.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

7.  Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis.

Authors:  Jean-Philippe Ranjeva; Bertrand Audoin; My Van Au Duong; My Van Au Duong; Danielle Ibarrola; Sylviane Confort-Gouny; Irina Malikova; Elisabeth Soulier; Patrick Viout; André Ali-Chérif; Jean Pelletier; Patrick Cozzone
Journal:  AJNR Am J Neuroradiol       Date:  2005-01       Impact factor: 3.825

8.  Corticomotor organisation and motor function in multiple sclerosis.

Authors:  Gary W Thickbroom; Michelle L Byrnes; Sarah A Archer; Allan G Kermode; Frank L Mastaglia
Journal:  J Neurol       Date:  2005-03-06       Impact factor: 4.849

9.  Sensorimotor cortex gamma-aminobutyric acid concentration correlates with impaired performance in patients with MS.

Authors:  P K Bhattacharyya; M D Phillips; L A Stone; R A Bermel; M J Lowe
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-14       Impact factor: 3.825

Review 10.  Ocular motor signatures of cognitive dysfunction in multiple sclerosis.

Authors:  Joanne Fielding; Meaghan Clough; Shin Beh; Lynette Millist; Derek Sears; Ashley N Frohman; Nathaniel Lizak; Jayne Lim; Scott Kolbe; Robert L Rennaker; Teresa C Frohman; Owen B White; Elliot M Frohman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.